← Eichor
Study identifier: NCT05723718 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment

Condition: Gastric Cancer · Gastric Adenocarcinoma · Malnutrition  ·  Sponsor: Medical University of Lublin

PhaseN/A
Planned participants125
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

The aim of this single-arm prospective, multicenter, cross-sectional study is to evaluate the nutritional status and body composition on tumor regression grade with bioelectrical impedance analysis in gastric cancer patients undergoing multimodal treatment. Results of this study will reveal whether nutritional status and body composition assessment based on bioelectrical impedance analysis will become a validated and objective tool to support clinical decisions in gastric cancer patients undergoing multimodal treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Zuzanna Pelc, PhD  ·  +48 81 531 81 26  ·  zuzannapelc@umlub.pl

Karol Rawicz-Pruszyński, Professor  ·  +48 81 531 81 26  ·  karol.rawicz-pruszynski@umlub.pl

Always discuss trial participation with your own doctor first.

Locations (1)

Medical University of LublinLublin, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05723718